A total of 284 Private Equity/Venture Financing deals (pending and completed) were announced in the Global Healthcare sector driven by Artificial Intelligence, in the last twelve months resulting in a total deal value of over $10,575.8 million. In the LTM period, June 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $196.0 million, resulting in an average deal value of $49.3 million during that month. On the other hand, the month of June 2021 was the most prolific in terms of deal volume, recording a total of 30 deals being made, with average deal value of $49.3 million during that month.
Of the 284 deals, the deal secured between Ally Bridge Group; Cambridge Innovation Capital Plc; Chimera Partners Limited; GE Healthcare; LGT Impact Ventures; Lightrock LLP; PFM Health Sciences LP; RPMI Railpen; SoftBank Vision Fund II; Tencent Holdings Ltd; Watrium AS and CMR Surgical Ltd, was the largest Private Equity/Venture Financing deal in the Global Healthcare sector driven by Artificial Intelligence, which was valued at $600.0 million and was completed on June 28, 2021. The second-largest deal was between Amgen Ventures LLC; Intermountain Ventures; McKesson Ventures; Merck Global Health Innovation Fund LLC; Northpond Ventures LLC; Pfizer Venture Investments; Population Health Partners LLC; The Carlyle Group Inc. and Saama Technologies Inc, while the third-largest deal was between 5Y Capital; Orbimed Advisors LLC; RRJ Capital; Sequoia Capital Operations LLC; Sino Biopharmaceutical Ltd and XtalPi Inc. The Amgen Ventures LLC; Intermountain Ventures; McKesson Ventures; Merck Global Health Innovation Fund LLC; Northpond Ventures LLC; Pfizer Venture Investments; Population Health Partners LLC; The Carlyle Group Inc.-Saama Technologies Inc deal and the 5Y Capital; Orbimed Advisors LLC; RRJ Capital; Sequoia Capital Operations LLC; Sino Biopharmaceutical Ltd-XtalPi Inc deal were valued at $430.0 million and $400.0 million, respectively. The fourth-largest deal was between B Capital Group Management, L.P.; Baidu Ventures; Bold Capital Partners; CITIC Industrial Investment Fund Management Co Ltd; Deerfield Management Co LP; Eight Roads Ventures; Formic Ventures; Lake Bleu Capital; Lilly Asia ventures; Maison Capital Group; Mirae Asset Capital Co Ltd; Orbimed Advisors LLC; Pavilion Capital Partners LLC; President International Development Corporation; Qiming Venture Partners; Sage Partners; Sequoia Capital China; Sinovation Ventures; Warburg Pincus LLC-InSilico Medicine valued at $255.0 million, whereas the deal between Mubadala Investment Co-Certara USA Inc valued at $250.0 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $1,935 million and accounted for nearly 18.30% of the total deals (by value) announced during the last twelve months. By region, North America accounted for 66.18% of the total Private Equity/Venture Financing deals done globally, and recorded a total deal value of $7,010.2 million, which accounted for 56.14% of the total deal size on a global scale.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer